In this Q and A, otolaryngologist Eric Smouha, MD, answers our questions about the possible association between COVID-19 infection and audio-vestibular symptoms, including the effects of SARS-CoV-2 virus on...
In Part 2 of this interview, Philipp Frank, PhD, discusses why paying attention to physical illness alongside mental health is an essential component of administering holistic health care.
Lead study author Lana Mucalo, MD, discusses her team’s study examining the prevalence of opioid-related mortality in patients with sickle cell disease from 2013 to 2019. She presented her research at the...
John Pierce, PhD, answers our questions about his team’s recent study that examined how youth e-cigarette use and other predictors impact the progression to later daily cigarette smoking.
In this Q&A, W. Clay Jackson, MD, answers questions about the positive and negative symptoms, the therapeutic challenges, the gold standard of treatment of patients with schizophrenia, and some...
In this Q&A, Jàn Varga, PhD, from Šafárik University and L. Pasteur University Hospital, discusses his recent study examining the predictive factors of endometriosis-associated ovarian cancer.
Tyler Morrissey, MD, discusses the results of his recent study examining the use of general anesthesia as a “teachable moment” for pediatric vaccination against seasonal influenza.
In this Q&A, Ping Liu, PhD, and Pietro Ravani, MD, PhD, answer our questions about the diagnosis and management of chronic kidney disease (CKD) and discuss how the current definition of CKD does not...
PrEP has become more mainstream in the media, and the USPSTF recently recommended PrEP for all at-risk populations. Richard Chaisson, MD, shines light on these at-risk populations.
